News coverage about Cantel Medical (NYSE:CMD) has been trending somewhat positive on Thursday, according to Accern Sentiment Analysis. The research group identifies negative and positive media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cantel Medical earned a coverage optimism score of 0.13 on Accern’s scale. Accern also assigned media stories about the company an impact score of 46.7600679669226 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
Cantel Medical (NYSE CMD) traded up $6.32 during trading hours on Thursday, hitting $106.53. 300,811 shares of the stock traded hands, compared to its average volume of 147,127. Cantel Medical has a 12-month low of $69.21 and a 12-month high of $108.00. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.49 and a current ratio of 2.41. The stock has a market cap of $4,450.00, a PE ratio of 48.31 and a beta of 1.24.
Cantel Medical (NYSE:CMD) last posted its earnings results on Thursday, September 28th. The company reported $0.54 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.52 by $0.02. Cantel Medical had a net margin of 9.27% and a return on equity of 17.60%. The firm had revenue of $205.50 million during the quarter, compared to analysts’ expectations of $200.32 million. The firm’s quarterly revenue was up 14.8% on a year-over-year basis. equities research analysts expect that Cantel Medical will post 2.34 earnings per share for the current fiscal year.
The firm also recently declared a Semi-Annual dividend, which will be paid on Wednesday, January 31st. Investors of record on Wednesday, January 17th will be paid a $0.085 dividend. This represents a dividend yield of 0.17%. This is a positive change from Cantel Medical’s previous Semi-Annual dividend of $0.07. The ex-dividend date is Tuesday, January 16th. Cantel Medical’s dividend payout ratio (DPR) is presently 8.19%.
Separately, Needham & Company LLC reaffirmed a “hold” rating on shares of Cantel Medical in a research report on Friday, September 1st. Four equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $91.67.
In related news, Director Mark N. Diker sold 7,000 shares of the stock in a transaction dated Tuesday, October 3rd. The shares were sold at an average price of $98.90, for a total value of $692,300.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Chairman Charles M. Diker sold 20,500 shares of the stock in a transaction dated Wednesday, October 4th. The stock was sold at an average price of $99.15, for a total transaction of $2,032,575.00. The disclosure for this sale can be found here. Over the last quarter, insiders sold 36,368 shares of company stock valued at $3,576,028. 12.30% of the stock is owned by company insiders.
ILLEGAL ACTIVITY WARNING: This report was first reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://ledgergazette.com/2017/12/07/somewhat-positive-press-coverage-somewhat-unlikely-to-impact-cantel-medical-cmd-share-price.html.
About Cantel Medical
Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with MarketBeat.com's FREE daily email newsletter.